Try one of the below options to narrow down your search.
![]() |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: EC
The term EC matches (either partially, or fully) a brand or chemical name in Pharmaceutical Schedule.
PHARMAC documents that matched your search:
Schedule Update - effective 1 June 2013
(41 pages, 586 KB)
2013/05/16
“EC 25 mg ............................................................................ 1.63 ❋Tab EC 50 mg ........................................................................... 1.60 (2.13) DOMPERIDONE ❋Tab 10 mg – For domperidone”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 June 2013 Cumulative for May and June 2013 Section H cumulative for April, May and June 2013 Contents Summary of PHARMAC decisions effective 1 June 2013 ….. 3 Blood glucose…
Pharmaceutical Schedule, May 2013
(256 pages, 1504 KB)
2013/05/01
“EC ✔ Videx EC ✔ Videx EC ✔ Videx EC EFAVIRENZ WITH EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE – Special”
May 2013 Volume 20 Number 1 Editors: Kaye Wilson, Donna Jennings & Sarah Le Leu email: schedule@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level 9, 40 Mercer Street PO Box 10 254 Wellington Freephone Information Line…
Schedule Update - effective 1 May 2013
(37 pages, 634 KB)
2013/04/19
“EC 25 mg; 100 tab Tab EC 50 mg; 500 tab Tab 10 mg; 100 tab Oral”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May 2013 Section H cumulative for April and May 2013 Contents Summary of PHARMAC decisions effective 1 May 2013 ….. 3 Amendment to restrictions for ciprofloxacin tablets and clindamycin …..…
Pharmaceutical Schedule - effective 1 April 2013
(243 pages, 1560 KB)
2013/04/03
“EC ✔ Videx EC ✔ Videx EC ✔ Videx EC EFAVIRENZ WITH EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE – Special”
Pharmaceutical Management Agency April 2013 New Zealand Pharmaceutical Schedule April 2013 Volume 20 Number 1 Editors: Kaye Wilson, Donna Jennings & Sarah Le Leu email: schedule@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level 9, 40 Mercer…
Schedule Update - effective 1 April 2013
(65 pages, 891 KB)
2013/03/19
“EC 25 mg .......................................................................... 4.00 ❋ Tab EC 50 mg ........................................................................ 16.00 LEVODOPA WITH CARBIDOPA (new formulation) Tab 100 mg with”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 April 2013 Cumulative for January, February, March and April 2013 Section H for April 2013 Contents Summary of PHARMAC decisions effective 1 April 2013 …. 3 Wastage Rule extended to…
Section H - effective 1 March 2013
(85 pages, 622 KB)
2013/02/26
“EC 25 mg – 1% DV Mar-13 to 2015..........................................................4.00 Tab EC 50 mg – 1% DV Mar-13 to 2015........................................................16.00 Tab long”
Pharmaceutical Management Agency Section H for Hospital Pharmaceuticals Effective 1 March 2013 New Zealand Pharmaceutical Schedule Hospital Pharmaceuticals March 2013 Editors Sarah Le Leu & Donna Jennings email: schedule@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level…
Schedule Update - effective 1 March 2013
(59 pages, 768 KB)
2013/02/18
“EC 25 mg .......................................................................... 4.00 ❋ Tab EC 50 mg ........................................................................ 16.00 LEVODOPA WITH CARBIDOPA (new formulation) Tab 100 mg with”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 March 2013 Cumulative for January, February and March 2013 Section H cumulative for December 2012, January, February and March 2013 Contents Summary of PHARMAC decisions effective 1 March 2013 …..…
Annual Review 2012
(36 pages, 2535 KB)
2013/01/31
“EC) schemes. NPPA has a number of advantages over the previous EC policies: • Rarity of the condition”
Pharmaceutical Management Agency Annual Review 2012 2011/12 Highlights Pharmaceutical funding • Community and cancer pharmaceutical funding managed on budget - $777.4 million • 24 new investments in medicine – including 14 new medicines and 10 widened access • New investments…
Notification A-Z list
(27 pages, 506 KB)
2013/01/29
“EC 25 mg Tab EC 50 mg Tab long-acting 100 mg Tab long-acting”
Funding decisions relating to hospital pharmaceuticals 29 January 2013 The following list details the pharmaceuticals that have been considered for inclusion in Part II of Section H of the Pharmaceutical Schedule from 1 July 2013. It relates to the first…
Schedule Update - effective 1 February 2013
(54 pages, 792 KB)
2013/01/22
“EC 25 mg .......................................................................... 4.00 ❋ Tab EC 50 mg ........................................................................ 16.00 LEVODOPA WITH CARBIDOPA (new formulation) Tab 100 mg with”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 February 2013 Cumulative for January and February 2013 Section H cumulative for December 2012, January and February 2013 Contents Summary of PHARMAC decisions effective 1 February 2013 …. 3 Extension…
Page updated on 23 May 2013



